MedPath

江西龙珠药业有限公司

Ownership
-
Established
2004-12-31
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

25

NMPA:25

Drug Approvals

Mannitol Injection

Product Name
甘露醇注射液
Approval Number
国药准字H36021966
Approval Date
Jul 17, 2022
NMPA

Sodium Bicarbonate Injection

Product Name
碳酸氢钠注射液
Approval Number
国药准字H36021490
Approval Date
Jul 17, 2022
NMPA

Mannitol Injection

Product Name
甘露醇注射液
Approval Number
国药准字H36021965
Approval Date
Jul 17, 2022
NMPA

Sodium Bicarbonate Injection

Product Name
碳酸氢钠注射液
Approval Number
国药准字H36021491
Approval Date
Jul 17, 2022
NMPA

鱼腥草注射液

Approval Number
国药准字Z36021412
Approval Date
Jul 17, 2022
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H36021487
Approval Date
Sep 21, 2010
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H36021481
Approval Date
Sep 21, 2010
NMPA

Compound Sodium Chloride Injection

Product Name
复方氯化钠注射液
Approval Number
国药准字H36021479
Approval Date
Sep 21, 2010
NMPA

Metronidazole and Sodium Chloride Injection

Product Name
甲硝唑氯化钠注射液
Approval Number
国药准字H36021572
Approval Date
Sep 21, 2010
NMPA

Metronidazole and Sodium Chloride Injection

Product Name
甲硝唑氯化钠注射液
Approval Number
国药准字H36021571
Approval Date
Sep 21, 2010
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.